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Inherited abnormalities of proteases or protease inhibitors have been shown to 
underlie a spectrum of skin barrier genodermatoses that lead to variable degrees of 
fragility, scaling and inflammation (reviewed in de Veer et al. [1]). One recent 
addition to this group is the autosomal recessive disorder, PLACK syndrome 
(OMIM616295). In 2015, Lin et al. [2] reported homozygous loss-of-function 
mutations in CAST (encoding calpastatin) in three families from different ethnic 
backgrounds (Chinese, Nepalese and European). Clinically, the signs comprised 
peeling skin, leukonychia, acral keratoses, cheilitis, and knuckle pads, hence the 
derivation of the acronym, PLACK syndrome. Calpastatin is an endogenous specific 
inhibitor of calpain, a calcium-dependent cysteine protease [3]. It is expressed in 
most tissues (except brain) with high expression of CAST noted in stratified 
squamous epithelia, including skin [3]. Loss of calpastatin in the affected individuals 
led to defective keratinocyte adhesion as well as increased keratinocyte apoptosis 
[2]. Three different homozygous mutations were reported: c.607dup 
(p.Ile203Asnfs*8), c.424A>T (p.Lys142*), and c.1750delG (p.Val584Trpfs*37) [2]. 
However, no further reports of PLACK syndrome have been documented thereafter. 
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Here, we outline the case of a 10 year old Tunisian boy, born to consanguineous 
parents, who presented with fragile blistering skin since birth. The parents described 
superficial post-traumatic or sometimes spontaneous superficial blisters mainly on 
his limbs. Typically these lesions healed completely within few days with mild 
superficial desquamation but without scarring. Furthermore, he also had chronic 
fissuring of the lips and around the mouth, as well as increasing pallor affecting all 20 
nails. He has a younger sister with normal skin but three third-degree cousins have 
been noted to have similar skin blistering (no further details available). 
Although the history raised the possibility of an intra-epidermal form of 
epidermolysis bullosa simplex [4], clinical examination demonstrated the full 
characteristic features of PLACK syndrome (Fig. 1). The punctate keratoses were 
most noticeable along the margins of the feet (Fig. 1c), but were also seen 
embedded within the knuckle pads on the fingers (Fig 1d). No mucous membrane 
involvement or hair abnormality was noted. The only other clinical finding was an 
abnormal gait: since the age of 4 years he had tended to walk on his toes. Full 
neurologic assessment by a pediatric neurologist revealed a slight weakness of the 
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reflexes and the proximal muscular strength of lower limbs, but the boy failed to 
attend for subsequent investigations or follow-up. The etiology of the walking 
anomaly is not known but is not thought to have any direct connection to the PLACK 
syndrome, although this cannot be completely discounted since some members of 
the calpain family have been implicated in muscular dystrophies [3, 5]. Of note, 
however, muscular dystrophy was not a feature present in the previous cases of 
PLACK syndrome [2]. 
Following informed consent, Sanger sequencing of the coding exons and 
flanking introns of CAST was performed using peripheral blood genomic DNA 
template sampled from the affected individual, which revealed a new homozygous 
4-base pair insertion, c.461dupGCAT (p.Ser154Cysfs*6) (Fig. 2a, b). This mutation 
does not appear in lists of polymorphic variants, such as the ExAC browser 
(http://exac.broadinstitute.org/). Similarly to the previously published data, this new 
mutation is sited within one of the calpain inhibitor domains of the protein (Fig. 2c). 
Unfortunately, parental DNA samples were not available for analysis. 
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Calpains represent a well-conserved family of calcium-dependent cysteine 
proteases with multiple ubiquitous and tissue specific isoforms identified [3, 5, 6]. 
Calpastatin is the natural endogenous inhibitor of calpain activity, specifically 
inhibiting calpain and not other cysteine proteases. Disruption of the 
calpain-calpastatin proteolytic system influences several aspects of cell biology, 
including migration, adhesion, proliferation and apoptosis, with clinical relevance 
already demonstrated in muscular dystrophy, cancer, Alzheimer's disease, 
neurological injury, ischemia/reperfusion injury, atherosclerosis, diabetes mellitus, 
cataract formation, and in PLACK syndrome [2, 3, 5, 6]. Knockout calpastatin mouse 
models display an unusual phenotype with decreased locomotor activity in stressful 
environments and a decreased auditory startle response, but abnormal movements 
or gait disturbances are not observed [7]. Different mouse models looking at 
calpastatin overexpression reveal delayed wound healing with reduced proliferation 
and re-epithelialization, particularly in the early phases of wound healing [8]. In 
contrast, all four human loss-of-function mutations in CAST (including this report) 
lead to a constellation of readily identifiable ectodermal anomalies and the clinical 
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entity of PLACK syndrome. Precisely how an imbalance in calpain-calpastatin 
proteolysis results in this particular syndrome, or what the phenotypic extent of this 
syndrome might be (e.g. additional muscular pathology) as further cases are 
reported, is uncertain. Nevertheless, we present the fourth example of PLACK 
syndrome to highlight the clinical and molecular features of this relatively newly 
described disorder. 
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Figure Legends 
Fig. 1. Clinical features of PLACK syndrome. (a) Peeling skin and superficial blistering 
of the lower limbs; (b) Cheilitis; (c) Acral punctate keratoses and superficial peeling 
on the sole; (d) Leukonychia and Knuckle pads.  
 
Fig. 2. CAST molecular pathology in PLACK syndrome. (a) Sanger sequencing reveals 
a homozygous 4-bp duplication in CAST (c.461dupGCAT; p.Ser154Cysfs*6). (b) 
Database of known mutations in CAST in PLACK syndrome. Previously described gene 
mutations are indicated in blue and the new mutation is depicted in green. 
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Fig. 1 
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Fig. 2 
 
 
 
 
